Symposium

Rehabilitation to Improve Functional Outcomes in Lung Cancer: A Clinical Practice Guideline 6481

Corresponding Presenter(s)

• 

  Laura Gilchrist, PT, PhD (she/her/hers)

  Endowed Chair Health Education and Research
  St. Catherine University
  Falcon Heights, MN, United States

  Slides

Presenter(s)

• 

  Mary Vargo, MD

  Professor, PM&R
  Case Western Reserve University, MetroHealth Rehabilitation Institute
  Cleveland, Ohio, United States
• 

  Mary I. Fisher, PT, PhD

  Professor, Department Chair and Program Director
  University of Dayton
  Dayton, OH, United States

Non-Presenting Contributor(s)

• 

  (Naomi) Lynn Gerber, MD

  Director for Research
  Inova Health System
  Bethesda, MD, United States

Lung cancer is one of the most common cancers and is associated with significant functional limitations. This high level of functional limitation may be amenable to cancer rehabilitation, and therefore, a clinical practice guideline was designed to assist clinicians with selecting the most efficacious interventions to improve function for this population. A multispecialty expert workgroup conducted a systematic review examining interventions for improving function at any stage or phase of disease. Quality assessment of all studies was conducted and practice recommendations were generated for functional outcomes of mobility, physical activity, social function, and general function. The resulting clinical practice recommendations will be reviewed and the challenges and opportunities to integrate these practice recommendations into clinical practice will be discussed. Participants will be asked to reflect on the congruence of these recommendations with their current practice and to identify areas where they could improve their clinical practice or fill evidence gaps.

Learning Objectives:

• Describe the process used to review the literature and create practice recommendations related to improving functional outcomes in persons who have experienced lung cancer.
• Describe rehabilitation interventions and the best known timing of their delivery intended to improve functional outcomes for people who have experienced lung cancer.
• Reflect on the congruence of the practice recommendations and their current practice
• Identify areas where they could improve clinical practice or fill evidence gaps.